These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 7638636

  • 1. Treatment of chronic myelogenous leukemia.
    Giralt S, Kantarjian H, Talpaz M.
    Semin Oncol; 1995 Aug; 22(4):396-404. PubMed ID: 7638636
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Prior treatment with alpha-interferon does not adversely affect the outcome of allogeneic BMT in chronic phase chronic myeloid leukemia.
    Zuffa E, Bandini G, Bonini A, Santucci MA, Martinelli G, Rosti G, Testoni N, Zaccaria A, Tura S.
    Haematologica; 1998 Mar; 83(3):231-6. PubMed ID: 9573677
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Indications, technique and risks in bone marrow transplantation in adulthood].
    Heyll A, Söhngen D, Minning H, Meckenstock G, Aul C, Schneider W.
    Praxis (Bern 1994); 1996 Mar 19; 85(12):378-86. PubMed ID: 8643901
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The evolving role of bone marrow transplantation in the treatment of chronic myelogenous leukemia.
    Delage R, Ritz J, Anderson KC.
    Hematol Oncol Clin North Am; 1990 Apr 19; 4(2):369-88. PubMed ID: 2182597
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Autologous bone marrow transplantation for leukemia.
    Stuart RK.
    Semin Oncol; 1993 Oct 19; 20(5 Suppl 6):40-54. PubMed ID: 8211215
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Role of pretransplant interferon-alpha(IFN) treatment in the outcome of stem cell transplantation (SCT) from related donors in chronic myelogenous leukemia (CML): results from three Turkish transplant centers.
    Beksac M, Celebi H, Sargín D, Yalcin A, Topcuoglu P, Kalayoglu-Besisik S, Beyan C, Arslan O, Ozcan M, Gurman G, Ilhan O, Akan H.
    Bone Marrow Transplant; 2003 May 19; 31(10):897-904. PubMed ID: 12748666
    [Abstract] [Full Text] [Related]

  • 12. Chronic myelogenous leukemia and acute promyelocytic leukemia: new bone marrow transplantation options.
    Viele CS.
    Oncol Nurs Forum; 1996 Apr 19; 23(3):488-93. PubMed ID: 8801509
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Chronic myelogenous leukemia: state of the art.
    Polli EE, Pozzoli E, Annaloro C.
    Ann Ital Med Int; 1991 Apr 19; 6(4 Pt 2):491-7. PubMed ID: 1840816
    [Abstract] [Full Text] [Related]

  • 15. Prolonged chronic phase in chronic myelogenous leukemia after homoharringtonine therapy.
    Li YF, Deng ZK, Xuan HB, Zhu JB, Ding BH, Liu XN, Chen BA.
    Chin Med J (Engl); 2009 Jun 20; 122(12):1413-7. PubMed ID: 19567163
    [Abstract] [Full Text] [Related]

  • 16. [Autologous hemopoietic stem cell transplantation in treatment of chronic myelogenous leukemia].
    Sacha T, Hawrylecka D, Skotnicki AB.
    Przegl Lek; 1999 Jun 20; 56 Suppl 1():62-6. PubMed ID: 10494185
    [Abstract] [Full Text] [Related]

  • 17. Fate of chronic myeloid leukemia patients treated with allogeneic bone marrow transplantation or chemotherapy and/or interferon at a single center: long-term results.
    Gaziev D, Galimberti M, Polchi P, Angelucci E, Giardini C, Baronciani D, Andreani M, Persini B, Erer B, Sodani P, Manna M, Nicolini G, Visani G, Lucarelli G, AIEOP.
    Bone Marrow Transplant; 2002 Jan 20; 29(1):1-8. PubMed ID: 11840137
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.